U.S. Stock News

ADT Inc.'s ( NYSE:ADT ) price-to-earnings (or "P/E") ratio of 10.2x might make it look like a buy right now compared to...

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...

While Golden Entertainment, Inc. ( NASDAQ:GDEN ) might not have the largest market cap around , it received a lot of...

When close to half the companies in the United States have price-to-earnings ratios (or "P/E's") below 18x, you may...

Quest Resource Holding Corporation ( NASDAQ:QRHC ) shareholders would be excited to see that the share price has had a...

Investors who take an interest in Energizer Holdings, Inc. ( NYSE:ENR ) should definitely note that the Independent...

It hasn't been the best quarter for World Acceptance Corporation ( NASDAQ:WRLD ) shareholders, since the share price...

Lincoln Educational Services Corporation ( NASDAQ:LINC ) shareholders would be excited to see that the share price has...

APA Corporation ( NASDAQ:APA ) shares have had a really impressive month, gaining 25% after a shaky period beforehand...

While Akso Health Group ( NASDAQ:AHG ) shareholders are probably generally happy, the stock hasn't had particularly...

With a median price-to-earnings (or "P/E") ratio of close to 19x in the United States, you could be forgiven for...

The Digital Turbine, Inc. ( NASDAQ:APPS ) share price has softened a substantial 31% over the previous 30 days, handing...

Many EverQuote, Inc. ( NASDAQ:EVER ) insiders ditched their stock over the past year, which may be of interest to the...

The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even...

MGP Ingredients, Inc.'s ( NASDAQ:MGPI ) price-to-sales (or "P/S") ratio of 0.9x might make it look like a buy right now...

Key Insights Significant control over CSP by individual investors implies that the general public has more power to...

Key Insights Significant insider control over iHuman implies vested interests in company growth Yufeng Chi owns 56% of...

Did you know there are some financial metrics that can provide clues of a potential multi-bagger? Typically, we'll want...

Kellanova (K) has quietly delivered steady gains over the past year, with the stock up about 6% and roughly 4% in the past 3 months, outpacing many packaged food peers. See our latest analysis for Kellanova. That steady climb reflects a market that is gradually rewarding Kellanova for consistent execution, with a 90 day share price return of just over 4% and a five year total shareholder return nearing 70%. This may hint that momentum is still quietly building. If Kellanova’s slow and steady...

If you are wondering whether New Fortress Energy is a bargain after its big sell off, you are not alone. This stock now sits in territory where price and value may be telling very different stories. In the very short term the shares have bounced, up 28.7% over the last week and 5.4% over the last month, but that comes after a brutal slide of 90.4% year to date and 87.3% over the past year. Those moves have unfolded against a backdrop of ongoing execution on its liquefied natural gas...

Dakota Gold (DC) is back on radar after fresh assay results from its Richmond Hill Oxide Heap Leach project confirmed high grade gold hits and step out drilling that pushes resource boundaries outward. See our latest analysis for Dakota Gold. The latest drill success comes on top of Dakota Gold’s recent conference appearances in London, and the market seems to be taking notice, with a year to date share price return of around 133 percent and a 1 year total shareholder return above 140...

If you have been wondering whether John Wiley & Sons at around $32 is a bargain or a value trap, you are not alone and this article is going to tackle that question head on. Despite being a long established name in publishing and research, the stock has had a rough ride lately, falling about 10.9% over the last week, 15.2% over the last month and roughly 24.9% year to date, which naturally raises questions about whether the market has become too pessimistic. Some of this share price weakness...

If you are wondering whether Avadel Pharmaceuticals at around $21 a share still has room to run or is already priced for perfection, you are not alone. This breakdown is designed to give you a clear, valuation focused view. The stock has dipped about 0.7% over the last week, but it is still up 12.6% over the past month and 94.0% year to date, with a 113.4% gain over the last year shifting how the market thinks about its risk and reward profile. Much of that surge has been driven by growing...

Wondering if Avidity Biosciences is still a smart buy after its huge run, or if most of the upside is already priced in? Here is a look at what the numbers suggest about value from here. The stock has cooled slightly in the last week, slipping about 0.1%, but it is still up 2.6% over the past month, 129.7% year to date, and 556.6% over 3 years, which indicates the market has rapidly rewritten its expectations. That surge in optimism has been driven largely by excitement around Avidity's...